Neuromuscular Monitoring of Rocuronium 0.6 mg/kg in Children Aged 3–24 Months With Electromyography and Acceleromyography: An Observational Study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Neuromuscular Function Following Rocuronium Administration (0.6 mg/kg) in Pediatric Patients Aged 3 to 24 Months Using Electromyography and Acceleromyography: An Observational Analysis

  • By

  • Sarah Sofie Wadland

  • Karl Peter Damgård Madsen

  • Mikkel Helmuth Jensen

  • Magnus Fuhr Hovind

  • Morten Sonne

  • Morten Bøttger

  • Arash Afshari

  • Frederik Mondrup

  • Matias Vested

  • May 19, 2026

Share

Objective:

To compare the time to TOFR ≥ 0.9 between acceleromyography (AMG) and electromyography (EMG) in children aged 3–24 months undergoing general anesthesia after administration of rocuronium 0.6 mg/kg.

Approach:
  • Study Design: An observational analysis involving 100 pediatric patients aged 3 to 24 months undergoing elective surgery under general anesthesia, comparing neuromuscular monitoring techniques.
  • Monitoring Techniques: Neuromuscular monitoring was performed using both acceleromyography (AMG) and electromyography (EMG) at either the tibial nerve (TN) or the ulnar nerve (UN) to assess the efficacy of each method.
  • Data Collection: Data on TOF responses were recorded and analyzed to determine the time to TOFR ≥ 0.9, focusing on the differences between AMG and EMG.
Key Findings:
  • Time to TOFR ≥ 0.9 was the primary outcome measured after administration of rocuronium 0.6 mg/kg.
  • Monitoring was performed at both TN and UN to assess the efficacy of AMG versus EMG.
Interpretation:

The study aimed to establish the effectiveness of AMG compared to EMG in monitoring neuromuscular function in young pediatric patients.

Limitations:
  • The study was limited to a specific age group (3 to 24 months) and may not be generalizable to older children or adults.
  • Potential variability in neuromuscular response due to individual patient factors was not fully addressed.
Conclusion:

The findings contribute to understanding neuromuscular monitoring in pediatric anesthesia, particularly regarding the use of AMG and EMG.

Original Source(s)

Related Content